Biochip for the early detection of cancer

The Innsbruck Biocentre, led by Professor Lukas Huber, is involved in a major European research project. This involves the development of a 'biological interface' for a new semiconductor developed by Siemens.

Lukas Huber (6th from the right), director of the Innsbruck Biocentre, with...
Lukas Huber (6th from the right), director of the Innsbruck Biocentre, with project partners from Germany, Finland, Sweden and Great Britain

The objective is to develop a chip that will be able to take numerous medical-diagnostic measurements simultaneously. This works by electronically recording and evaluating changes in the chip’s frequency patterns. Certain proteins, or DNA-sequences, are fixed onto the sensor area of the chip, which, when coming into contact with other proteins (via a drop of blood, for example) cause changes in the frequency pattern. To put it simply, these reactions could be detected and immediately evaluated through a special reader.

The researchers hope to extract a multitude of information from just a single drop of blood or serum, which could revolutionise the diagnoses of complex diseases, such as certain types of cancer.

With their Innsbruck research team, Prof. Huber and Prof. M Widschwendter are concentrating on the proteins and DNA-sequences, as well as on the development of the relevant markers, which, once fixed to the chip, will deliver that information. Researchers at the Technical Research Centre VIT, in Helsinki, are working on a process to chemically fix the DNA-strings from Austria to the measuring field. The test models finally will end up at Siemens, in Munich, where the new semiconductor-technology is being further refined. Other partners in the project, for which the EU has provided subsidies totalling Ä3.8 million until 2008, are based in Great Britain and Sweden.


More on the subject:More on companies:
Read all latest stories

Related articles


Improvement of cardiac care

Rapid myocardial infarction verification

The use of troponin assays to rule in or rule out myocardial infarction (MI) rapidly is critical on several levels. The quick result can reassure the patient that they have not had a heart attack and…



AI helpers simplify clinical MRI scans

The new 1.5 Tesla MRI from Siemens Healthineers, Magnetom Sola, is packed with helpful algorithms and other functions. AI-supported systems monitor patients and scan parameters and ensure consistent…


Lab equipment

It takes a team

Clinical laboratories need to meet greater testing demands, improve efficiency, and deliver reliable, high-quality results, while at the same time, facing an increasing shortage of skilled employees…

Related products